Status:
TERMINATED
Natural History of Autoimmune Diabetes and Its Complications
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Eligibility:
All Genders
2+ years
Brief Summary
Background: * Diabetes is a disease defined by abnormally high blood sugar (glucose) levels. Glucose is an essential source of energy for the body s cells, but insulin is required to move the glucose...
Detailed Description
Individuals with known or suspected autoimmune mediated diabetes, or healthy individuals at risk for developing the disease, will be evaluated at the NIH Clinical Center. Studies will include characte...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- i. Clinical diagnosis of diabetes, either type 1 (T1D) or insulin-requiring type 2 (T2D),
- ii. Healthy individuals who may be at risk for developing diabetes,
- iii. Individuals with suspected immune mediated diabetes,
- iv. Willingness of the patient or guardian to give informed consent and assent.
- EXCLUSION CRITERIA:
- i. Concomitant medical problems which would confound the interpretation studies of the autoimmune beta cell destructive process
- ii. Concomitant medical, surgical, or other conditions for which adequate facilities or funds are not available to support their care at the NIH.
- iii. Any other co-existing condition/circumstances that would make a subject unsuitable to participate in the study, as deemed by the investigators.
Exclusion
Key Trial Info
Start Date :
May 13 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT00896610
Start Date
May 13 2009
End Date
September 30 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892